Form 4: Ocular Therapeutix Chief Strategy Officer Sells Shares to Cover Tax Obligations

Sanjay Nayak, Chief Strategy Officer of Ocular Therapeutix, sold 2,274 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• On May 23, 2024, Sanjay Nayak, the Chief Strategy Officer of Ocular Therapeutix, Inc., sold 2,274 shares of common stock.
• The sale was executed at a weighted average price of $5.84 per share, with individual transactions ranging from $5.77 to $5.92.
• The sale was conducted automatically under a pre-arranged plan adopted on February 21, 2024, to cover tax withholding obligations related to the vesting of restricted stock units on May 22, 2024.
• Following the transaction, Nayak still beneficially owns 178,026 shares of Ocular Therapeutix common stock.

Sentiment

Score: 6

Explanation: The document is neutral. It simply reports a routine stock sale for tax purposes. There is no indication of positive or negative sentiment regarding the company's prospects.

Industry Context

Insider sales are a common occurrence, especially to cover tax obligations related to equity compensation. The fact that this sale was pre-planned under a Rule 10b5-1 plan suggests it was not based on any inside information.

Stakeholder Impact

• The sale of shares by an officer could have a minor negative impact on shareholder sentiment, but the pre-planned nature of the sale mitigates this concern.

Key Dates